Provided by Tiger Trade Technology Pte. Ltd.

Eloxx Pharmaceuticals (Uplisting)

15.51
-0.2000-1.27%
Post-market: 15.510.00000.00%19:30 EDT
Volume:17.71K
Turnover:271.22K
Market Cap:62.60M
PE:-5.44
High:16.02
Open:15.92
Low:14.91
Close:15.71
52wk High:23.40
52wk Low:0.0000
Shares:4.04M
Float Shares:2.39M
Volume Ratio:1.18
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8493
EPS(LYR):-5.3408
ROE:-615.23%
ROA:-97.59%
PB:1.35
PE(LYR):-2.90

Loading ...

Eloxx Pharmaceuticals initiated with an Outperform at Leerink

TIPRANKS
·
Sep 18

Eloxx Pharmaceuticals Inc : Leerink Partners Initiates Coverage with Outperform Rating; Target Price $32

THOMSON REUTERS
·
Sep 18

U.S. Research Roundup-Amrize, Carmax, VF Corp

Reuters
·
Sep 18

Eloxx Pharmaceuticals files to sell 600,000 shares of common stock for holders

TIPRANKS
·
Sep 12

Eloxx Pharmaceuticals - Topline Data from 16-Week Study Expected Mid-2027; Final Readout by End of 2027

THOMSON REUTERS
·
Sep 11

Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2B Exact Study of Exaluren in Nonsense Mutation Alport Syndrome

THOMSON REUTERS
·
Sep 11

Eloxx Pharmaceuticals Price Target Maintained with a $43.00/Share by Guggenheim

Dow Jones
·
Aug 24

Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL)

TIPRANKS
·
Aug 24

Eloxx Pharmaceuticals Price Target Announced at $38.00/Share by LUCID Capital Markets

Dow Jones
·
Aug 20

Eloxx Pharmaceuticals initiated with a Buy at Lucid Capital

TIPRANKS
·
Aug 20

CAMP4 Therapeutics Q2 Loss Per Share Misses Estimates on Non-Cash Derivative Charge

Reuters
·
Aug 14

Grace Therapeutics Q1 Net Loss Widens on Impairment Charges

Reuters
·
Aug 13

Belite Bio Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 13

Spruce Biosciences Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 12

Eloxx Maintained at Buy as Strong Exaluren Pipeline and Solid Cash Runway Support Unchanged $40 Price Target

TIPRANKS
·
Aug 12

Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 12

Eloxx Rugi Bersih Q2 FY26 Melebar 138% Menjadi USD 4,5 Juta

Reuters
·
Aug 12

Eloxx Pharmaceuticals Initiated at Outperform by Lifesci Capital

Dow Jones
·
Jul 23

Eloxx Pharmaceuticals initiated with an Outperform at LifeSci Capital

TIPRANKS
·
Jul 22

Eloxx Pharmaceuticals Initiated at Buy by Guggenheim

Dow Jones
·
Jul 20